@article{aba3752a98bd480c927c6eb29db9915e,
title = "The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control",
author = "{the Japanese encephalitis vaccination experts panel} and Vannice, {Kirsten S.} and Hills, {Susan L.} and Schwartz, {Lauren M.} and Barrett, {Alan D.} and James Heffelfinger and Joachim Hombach and Letson, {G. William} and Tom Solomon and Marfin, {Anthony A.} and Katie Anderson and Marc Fischer and Kim Fox and Julie Jacobson and Jayantha Liyanage and Florian Marks and Ike Ogbuanu and Piyanit Tharmaphornpilas",
note = "Funding Information: No conflicts of interest: G.W.L., J.M.H., J.H., S.H., L.M.S., K.V., A.A.M. T.S. is supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (Grant No. IS-HPU-1112-10117), NIHR Global Health Research Group on Brain Infections (No. 17/63/110), and the European Union{\textquoteright}s Horizon 2020 research and innovation program ZikaPLAN (Preparedness Latin America Network), grant agreement No. 734584. A.D.T.B. is Editor in Chief of npj Vaccines. Funding Information: This meeting was supported by Bill & Melinda Gates Foundation grants to US Centers for Disease Control and Prevention and PATH. In addition, the authors are grateful to the Bill and Melinda Gates Foundation for hosting the expert consultation. The findings and conclusions in this report are those of the authors and do not represent the official position of the Centers for Disease Control and Prevention or the World Health Organization.",
year = "2021",
month = dec,
doi = "10.1038/s41541-021-00338-z",
language = "English (US)",
volume = "6",
journal = "npj Vaccines",
issn = "2059-0105",
publisher = "Nature Publishing Group",
number = "1",
}